--- title: "在周三的交易中，作为美国存托凭证交易的欧洲股票上涨" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/277809914.md" description: "在美国交易的欧洲股票中，标准普尔欧洲精选 ADR 指数的美国存托凭证上涨了 0.82%，达到 1,778.79。显著上涨的股票包括 Cellectis (CLLS) 和 Sequans Communications (SQNS)，分别上涨了 5.7% 和 5.3%。Banco Santander (SAN) 和 BBVA 也有所上涨。下跌的股票包括 Evaxion (EVAX) 和 Anheuser-Busch InBev (BUD)。来自英国的 Endava (DAVA) 和 Akari Therapeutics (AKTX) 领涨，而 Silence Therapeutics (SLN) 和 Diageo (DEO) 则在下跌之列。MT Newswires 不提供投资建议" datetime: "2026-03-04T16:09:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277809914.md) - [en](https://longbridge.com/en/news/277809914.md) - [zh-HK](https://longbridge.com/zh-HK/news/277809914.md) --- # 在周三的交易中，作为美国存托凭证交易的欧洲股票上涨 11:09 AM EST, 03/04/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 0.82% to 1,778.79 on the S&P Europe Select ADR Index. From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and semiconductor company Sequans Communications ( SQNS ) , which rose 5.7% and 5.3% respectively. They were followed by lenders Banco Santander (SAN) and Banco Bilbao Vizcaya Argentaria ( BBVA ) , which advanced 5% and 4.7% respectively. The decliners from continental Europe were led by biotech firm Evaxion ( EVAX ) and brewing company Anheuser-Busch InBev ( BUD ) , which fell 2.2% and 1.4% respectively. They were followed by pharmaceutical company Sanofi ( SNY ) and consumer goods company Unilever ( UL ) , which were down 0.8% and 0.6% respectively. From the UK and Ireland, the gainers were led by software firm Endava ( DAVA ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which increased 8.3% and 7.2% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and biotech firm Autolus Therapeutics ( AUTL ) , which were up 4.1% and 4% respectively. The decliners from the UK and Ireland were led by pharmaceutical company Silence Therapeutics ( SLN ) and alcoholic beverage company Diageo ( DEO ) , which dropped 4.4% and 3.4% respectively. They were followed by medical device maker Smith & Nephew ( SNN ) and biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which lost 2.2% and 1.1% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited. ### 相关股票 - [EVAX.US](https://longbridge.com/zh-CN/quote/EVAX.US.md) - [BBVA.US](https://longbridge.com/zh-CN/quote/BBVA.US.md) - [DGE.UK](https://longbridge.com/zh-CN/quote/DGE.UK.md) - [CLLS.US](https://longbridge.com/zh-CN/quote/CLLS.US.md) - [AKTX.US](https://longbridge.com/zh-CN/quote/AKTX.US.md) - [SAN.US](https://longbridge.com/zh-CN/quote/SAN.US.md) ## 相关资讯与研究 - [德国转变态度，欧洲准备 “脱美方案”：北约和霍尔木兹海峡，欧洲要自己解决](https://longbridge.com/zh-CN/news/282766377.md) - [特斯拉终于在欧洲获得绿灯 FSD 获批标志着期待已久的进展](https://longbridge.com/zh-CN/news/282548986.md) - [美媒：研发投资 “腰斩”，欧洲制药业基石动摇](https://longbridge.com/zh-CN/news/282597785.md) - [三周内，欧洲机场燃油告急](https://longbridge.com/zh-CN/news/282405359.md) - [空头大军压境欧洲！对冲基金创纪录做空欧股，空仓披露数量创 2012 年以来新高](https://longbridge.com/zh-CN/news/281945005.md)